Amy Parison
SVP, Chief Financial Officer · Editas Medicine, Inc.
- 2025
- Sep 4, 2026
- 8
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Amy Parison files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Gilmore Neil O'Neill - $80K in EDIT purchases and sales in the last 12 months
- Linda Burkly - $19K in EDIT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Amy Parison?
Amy Parison is a corporate insider, tracked as SVP, Chief Financial Officer of Editas Medicine, Inc. (EDIT). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Amy Parison submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Amy Parison been buying or selling stock?
Recorded transactions: 0 open-market purchases and 7 open-market sales ($9K) across all tracked filings.
